retatrutide triple hormone receptor agonist metabolic Dr Today, we shared new data

Our analysis also suggests more pronounced effects with short-acting agents (such as exenatide and lixisenatide) and in earlier treatment phases ( 2), which could have implications for perioperative care

Women of childbearing age are typically required to use effective contraception and test negative for pregnancy before starting it

Clinical trials examining medication discontinuation have consistently demonstrated significant weight regain after stopping GLP-1 therapy

doi: Tiloke, C., Phulukdaree, A., & Chuturgoon, A

By engaging the glucagon receptor in addition to the two incretin receptors, retatrutide is hypothesized to add a direct energy-expenditure component to the appetite-suppressing and glucose-regulating effects already established for GLP-1 and GIP agonism

I also have patients checking their body composition via the InBody about once a month so we can assess whats going on with muscle mass and fat loss